Coloplast announces changes to Executive Leadership Team

Leadership Changes - Coloplast is announcing changes to its Executive Leadership Team (ELT), specifically in the Interventional Urology business and the global People & Culture function [1] - Dorthe Rønnau, Executive Vice President of People & Culture, will leave the company after nearly three decades to pursue other opportunities [1][2] - An external search is underway for a new leader for the global People & Culture function, with Mads Mikkelsen taking over interim leadership until a permanent successor is found [3] Retirement and Succession - Tommy Johns, Executive Vice President of Interventional Urology, will retire early next year after over a decade with Coloplast and more than thirty years in the global life science industry [4] - Kevin Hardage will assume the role of Executive Vice President of Interventional Urology starting February 9th, bringing extensive experience from the global MedTech industry [6] - There will be an overlap period between Tommy Johns and his successor to ensure a thorough handover [5] Leadership Perspectives - Lars Rasmussen, interim CEO of Coloplast, praised both Dorthe Rønnau and Tommy Johns for their contributions and expressed confidence in Kevin Hardage's ability to lead the Interventional Urology business into a new growth phase [7]